A Phase 1 Study of LNCB74 in Advanced Solid Tumors
for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: Boston MA, Philadelphia PA, Falls Church VA, Buffalo NY,
Sponsor: NextCure, Inc.
Sex: All
Age: 18+
Code: NCT06774963
Phase1, Recruiting
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
for
Non-small Cell Lung Cancer
Location: New York NY, Tampa FL, Athens GA, Des Moines IA,
Sponsor: Teligene US
Sex: All
Age: 18+
Code: NCT06010329
Phase2, Recruiting
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
for
Non Small Cell Lung Cancer, Small Cell Lung Carcinoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 15+
Code: NCT05265429
Recruiting
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05424029
Recruiting
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
for
Non Small Cell Lung Cancer, Healthy
Location: Dallas TX
Sponsor: OncoHost Ltd.
Sex: All
Age: 18+
Code: NCT05736029
Recruiting
Interested in new non-small cell lung cancer trials?
Get alerts for new trials in your area by subscribing now
Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer Stage IB (Resectable),
Location: London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Sex: All
Age: 18+
Code: NCT06250829
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)